Karyopharm Therapeutics(KPTI)
Focus: Karyopharm is a public biotechnology company focused on small-molecule therapeutics for oncology and hematology, headquartered in Newton, MA. The company maintains a lean R&D-intensive operation with a diversified pipeline centered on its lead asset selinexor.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
9+5 this month
Growing — net +5 jobs in 30d
6 jobs added vs 1 removed. Steady team buildout.
Should You Work at Karyopharm Therapeutics?
AI assessmentKaryopharm offers meaningful oncology R&D work and pipeline optionality, but severe cash constraints and minimal hiring make it a higher-risk career move best suited for mission-driven scientists willing to tolerate restructuring likelihood.
Why Work Here
- Selinexor pipeline spans 17 clinical programs across multiple cancer types with Phase 3 programs in endometrial cancer and myelofibrosis offering near-term catalysts
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
50 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$146M
Pipeline & Clinical Trials
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression
Polycythemia VeraClinical Trials (1)
NCT07362225MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
N/AHelp build intelligence for Karyopharm Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.